Published in Expert Rev Pharmacoecon Outcomes Res on October 01, 2001
A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med (2009) 1.99
A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis. BMJ (2006) 1.65
Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes. Value Health (2011) 1.03
Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR). BMC Health Serv Res (2008) 0.95
Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. Eur J Health Econ (2004) 0.85
The impact of an exercise physiologist coordinated resistance exercise program on the physical function of people receiving hemodialysis: a stepped wedge randomised control study. BMC Nephrol (2013) 0.79
Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer. Br J Cancer (2008) 0.79
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1. BMC Cancer (2013) 0.78
A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials. BMJ Open (2013) 0.78
Laparoscopic totally extraperitoneal versus open preperitoneal mesh repair for inguinal hernia recurrence: a decision analysis based on net health benefits. Surg Endosc (2013) 0.78
Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis. BMC Anesthesiol (2007) 0.77
The cost-effectiveness of providing antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMC Obes (2015) 0.77
Coaching Older Adults and Carers to have their preferences Heard (COACH): A randomised controlled trial in an intermediate care setting (study protocol). Australas Med J (2012) 0.76
Combining Time-Driven Activity-Based Costing with Clinical Outcome in Cost-Effectiveness Analysis to Measure Value in Treatment of Depression. PLoS One (2016) 0.75
A health economic model for the development and evaluation of innovations in aged care: an application to consumer-directed care-study protocol. BMJ Open (2014) 0.75
Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial. PLoS One (2017) 0.75
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev (1997) 2.47
Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract (2000) 2.34
Ultraviolet A and melanoma: a review. J Am Acad Dermatol (2001) 2.27
Noninvasive genomic detection of melanoma. Br J Dermatol (2011) 2.17
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS (1998) 1.94
Nursing shortages and international nurse migration. Int Nurs Rev (2005) 1.53
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res (2002) 1.52
Microtubule bending and breaking in living fibroblast cells. J Cell Sci (1999) 1.29
Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med (2007) 1.25
Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry. Br J Dermatol (2005) 1.23
Self-reported physician specialties and the primary care content of medical practice: a study of the AMA physician masterfile. American Medical Association. Med Care (1999) 1.22
The effect of HMO penetration on physician retirement. Health Serv Res (2000) 1.20
How cost-effective is screening for abdominal aortic aneurysms? J Med Screen (2007) 1.14
Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health Econ (2001) 1.07
Health maintenance organization penetration and the practice location choices of new physicians: a study of large metropolitan areas in the United States. Med Care (1998) 1.05
Effects of manganese on the response of aortic strips to angiotensin and norepinephrine contractions. J Pharmacol Exp Ther (1968) 1.04
A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making (1999) 1.02
HMO growth and the geographical redistribution of generalist and specialist physicians, 1987-1997. Health Serv Res (2000) 0.98
Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ (1998) 0.98
Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'? Dermatology (2012) 0.97
High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer (2001) 0.96
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. Science (1982) 0.95
Whole brain methionine-enkephalin of ethanol-avoiding and ethanol-preferring c57BL mice. Experientia (1982) 0.94
Mechanical activity of vascular smooth muscle under anoxia. Am J Physiol (1967) 0.92
Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Br J Cancer (2010) 0.88
Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin. Proc Natl Acad Sci U S A (1983) 0.88
A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK Counterweight programme. Int J Obes (Lond) (2012) 0.88
Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice. Alcohol (1988) 0.85
Interaction of hydralazine with tension development and mechanisms of calcium accumulation in K+-stimulated rabbit aortic strips. J Pharmacol Exp Ther (1978) 0.85
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. Am Heart J (2001) 0.82
Reduction of ultraviolet transmission through cotton T-shirt fabrics with low ultraviolet protection by various laundering methods and dyeing: clinical implications. J Am Acad Dermatol (2001) 0.82
Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome. Clin Exp Dermatol (2005) 0.81
Ethanol preference as a function of genotypic levels of whole brain enkephalin in mice. Toxicol Eur Res (1981) 0.81
Ca and ouabain interaction on vascular smooth muscle. Proc Soc Exp Biol Med (1966) 0.81
The relationships between electrical and mechanical events in rabbit aortic strips. J Pharmacol Exp Ther (1966) 0.81
Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology (2007) 0.81
Evidence for the importance of the "genotype" theory in alcohol seeking behavior: a commentary. Alcohol Drug Res (1986) 0.81
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BJOG (2013) 0.81
Psychogenetics of drug seeking behavior. Subst Alcohol Actions Misuse (1980) 0.79
Naloxone antagonizes the action of low ethanol concentrations on mouse vas deferens. Subst Alcohol Actions Misuse (1980) 0.78
Analytic approaches for the evaluation of costs. Hepatology (1999) 0.78
Ethanol ingestive behavior as a function of central neurotransmission. Experientia (1989) 0.78
Clonidine enhancement of ethanol withdrawal in mice. Subst Alcohol Actions Misuse (1983) 0.77
Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. Stroke (1998) 0.77
Genotype dependent responses to ethanol and normorphine on vas deferens of inbred strains of mice. Subst Alcohol Actions Misuse (1980) 0.76
Methionine enkephalin as a possible neuromodulator of regional cerebral blood flow. Experientia (1985) 0.76
Opioid responses of isoquinoline alkaloids (TIQs). Prog Clin Biol Res (1982) 0.76
Ethanol intoxication as a function of genotype dependent responses in three inbred mice strains. Pharmacol Biochem Behav (1982) 0.76
Regional brain [Met]-enkephalin in alcohol-preferring and non-alcohol-preferring inbred strains of mice. Experientia (1987) 0.76
Supersensitivity to norepinephrine induced by prenatal exposure to ethanol. Eur J Pharmacol (1984) 0.75
Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia. Int J Technol Assess Health Care (1998) 0.75
The effects of haloperidol on ouabain cardiac inotropy and toxicity. Proc Soc Exp Biol Med (1978) 0.75
Holism: a social pharmacological approach to drug-seeking behavior. J Psychoactive Drugs (1982) 0.75
FOUND-PATHOLOGICAL SPECIMENS. Br J Ophthalmol (1947) 0.75
Calcium uptake in isolated skeletal muscle "sarcoplasmic reticulum" from rats with drug induced myotonia. Proc Soc Exp Biol Med (1968) 0.75
Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens. Funct Neurol (1987) 0.75
Epinephrine potentiation in isolated rabbit aortic strips. J Pharmacol Exp Ther (1967) 0.75
Can we prevent drug abuse in industry? Tex Med (1974) 0.75
Drug therapy in hypertension. Med Times (1966) 0.75
SILENT SINUSITIS. Br J Ophthalmol (1944) 0.75
An improved technique for the induction of barbiturate dependence in mice. J Pharmacol Methods (1980) 0.75
Factors affecting contraction and relaxation in dog glycerinated cardiac fibers. Am J Physiol (1966) 0.75
Receptor mechanism concepts. Clin Anesth (1974) 0.75
A rapid method of evaluate acute ethanol intoxication in mice. Pharmacol Biochem Behav (1981) 0.75
On the mechanism of methadone-induced alcohol consumption in humans. Subst Alcohol Actions Misuse (1982) 0.75
Effects of delta9 tetrahydrocannabinol (delta9-THC) on amphetamine-aggregate toxicity in mice. Curr Ther Res Clin Exp (1977) 0.75
A comparison of calcium dependent contraction in glycerinated uterine smooth muscle and cardiac muscle. Proc Soc Exp Biol Med (1967) 0.75
Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man. J Pharmacokinet Biopharm (1979) 0.75